Skip to main content

Special Features - Covid-19: Regulatory issues for hand sanitiser

Anita Lloyd and Nicola Smith, directors in the Environmental, Safety & Health Group of Squire Patton Boggs, look at the key issues for companies starting to manufacture or import hand sanitiser

Many companies are looking at modifying their production lines and/or utilising spare capacity to manufacture hand sanitiser, which is in short supply due to the Covid-19 pandemic. Others may be looking into importing this product into the UK for the first time.

Feature Article – Covid-19 update: How the industry is responding

The news is entirely dominated by the coronavirus pandemic. Here, we summaries some of the key developments in the fine and speciality chemicals industry so far in April

Multiple companies are turning spare capacity over or building new capacity to supply hand sanitiser. Leading the way is Ineos, which had already built three such plants in the UK, France and Germany and has now announced plans to build a fourth at Etian, France, to serve hospitals in Paris, north-eastern France and Belgium.

AGC expands Spanish site

AGC has announced plans to expand its CDMO subsidiary, AGC Pharma Chemicals Europe. As well as adding 30% to the capacity of its production facilities by May 2022, this will see the addition of a new micronisation facility and a new R&D facility, which is due to begin operation in March 2021. The plant, near Barcelona, was originally known as Malgrat Pharma Chemicals.

Exclusive negotiations for Schülke & Mayr sale

Air Liquide has entered into exclusive negotiations with EQT, a differentiated global investment firm with over €62 billion in raise capital, for the sale of its Schülke & Mayr subsidiary. The company had announced its intention to sell Schülke & Mayr in November 2019 as part of a strategy of focusing on its core gases and healthcare businesses.

Round one to DuPont over Chemours in legal battle

The first step in ongoing litigation in the US between Chemours and its parent firm DuPont over the cost of environmental liabilities relating to historic pollution caused by per- and polyfluoroalkyl substances (PFASs) went DuPont’s way on 2 April. Chemours has said that it will appeal to the Delaware Supreme Court.

Arkema to focus on speciality materials

Arkema has held a strategy update meeting, at which it presented “its ambition to become a world leader in speciality materials, realigned around three coherent businesses with attractive growth prospects”. By 2024, it aims to be a pure player in this field with “a resilient and focused portfolio, characterised by high profitability and strong cash generation”.

Feature Article - Accurate readings in analytical balances

Kevin Hill of Quality Scales Unlimited offers some must-follow tips for accurate weighing of laboratory samples

It is easy to assume that using the right kind of analytical balance as per your weighing purpose is enough to weigh laboratory samples accurately. But what’s even more important is handling the balance and weighing samples with care.

Why? Analytical balances are often subject to reading errors if not handled properly. The reason is that they are extremely sensitive and their readings can easily be affected by small factors such as:

Subscribe to Current issue